Highline Wealth Partners LLC Organon & Co. Transaction History

Highline Wealth Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Oct 28, 2024	SELL	$10.95 - $17.32 $21 - $34	-2 Closed	0 $0
Q3 2023 Oct 28, 2024	BUY	$16.59 - $23.77 $33 - $47	2 New	2 $35,000
Q1 2023 Oct 28, 2024	BUY	$21.42 - $32.08 $0 - $0	0 New	0 $0
Q4 2022 Oct 29, 2024	BUY	$23.31 - $28.61 $116 - $143	5 New	5 $140,000
Q3 2022 Oct 29, 2024	BUY	$23.4 - $34.25 $117 - $171	5 New	5 $117,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Highline Wealth Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Highline Wealth Partners LLC with notifications on news.